Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

New insights into Perrault syndrome, a clinically and genetically heterogeneous disorder

Genomic sequencing highlights the diverse molecular causes of Perrault syndrome: a peroxisomal disorder (PEX6), metabolic disorders (CLPP, GGPS1), and mtDNA maintenance/translation disorders (LARS2, TFAM)

Delayed Diagnosis of Perrault Syndrome: A Rare Genetic Disorder

LARS2-Perrault syndrome: a new case report and literature review

Axonal polyneuropathy and ataxia in children: consider Perrault Syndrome, a case report

Biallelic mutations in LARS2 can cause Perrault syndrome type 2 with neurologic symptoms

Clinical and genetic analysis of a patient with Perrault syndrome and additional neurological features

A Homozygous Missense Variant in HSD17B4 Identified in a Consanguineous Chinese Han Family with Type II Perrault Syndrome

Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome

Homozygous novel truncating variant of CLPP associated with severe Perrault syndrome

First independent replication of the involvement of LARS2 in Perrault syndrome by whole-exome sequencing of an Italian family

A Novel Missense Mutation in TWNK Gene Causing Perrault Syndrome Type 5 in a Chinese Family and Review of the Literature

Detailed characterization of auditory neuropathy in Perrault syndrome with TWNK variants

LARS2 variants can present as premature ovarian insufficiency in the absence of overt hearing loss

A novel mutation of Twinkle in Perrault syndrome: A not rare diagnosis?

Exome sequencing reveals pathogenic mutations in the LARS2 and HSD17B4 genes associated with Perrault syndrome and D-bifunctional protein deficiency in Moroccan families

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

Mutations in Twinkle primase-helicase cause Perrault syndrome with neurologic features

Clinical and Molecular Diagnosis in a Big Chinese Family with Pendred Syndrome

Novel Pathogenic OCRL Mutations and Genotype-Phenotype Analysis of Chinese Children Affected by Oculocerebrorenal Syndrome: Two Cases and a Literature Review.

Genotype-phenotype spectrum and correlation of PHARC Syndrome due to pathogenic ABHD12 variants